desmethylastemizole has been researched along with sotalol in 1 studies
Studies (desmethylastemizole) | Trials (desmethylastemizole) | Recent Studies (post-2010) (desmethylastemizole) | Studies (sotalol) | Trials (sotalol) | Recent Studies (post-2010) (sotalol) |
---|---|---|---|---|---|
12 | 1 | 2 | 2,196 | 346 | 291 |
Protein | Taxonomy | desmethylastemizole (IC50) | sotalol (IC50) |
---|---|---|---|
Beta-2 adrenergic receptor | Homo sapiens (human) | 3.8169 | |
Beta-1 adrenergic receptor | Homo sapiens (human) | 7.1087 | |
Beta-3 adrenergic receptor | Homo sapiens (human) | 7.2 | |
Beta-2 adrenergic receptor | Canis lupus familiaris (dog) | 5.0667 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bianucci, AM; Calderone, V; Coi, A; Massarelli, I; Testai, L | 1 |
1 other study(ies) available for desmethylastemizole and sotalol
Article | Year |
---|---|
Identification of "toxicophoric" features for predicting drug-induced QT interval prolongation.
Topics: Amino Acid Sequence; Heart; Humans; Models, Molecular; Molecular Sequence Data; Molecular Structure; Protein Subunits; Sequence Alignment; Structure-Activity Relationship; Trans-Activators; Transcriptional Regulator ERG | 2008 |